• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肺部病毒和过敏原免疫的重叠和独特特征。

Overlapping and distinct features of viral and allergen immunity in the human lung.

机构信息

National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.

National Heart and Lung Institute, Imperial College London, London SW7 2AZ, UK.

出版信息

Immunity. 2021 Apr 13;54(4):617-631. doi: 10.1016/j.immuni.2021.03.010.

DOI:10.1016/j.immuni.2021.03.010
PMID:33852829
Abstract

Immunity in the human respiratory tract is provided by a diverse range of tissue-resident cells, including specialized epithelial and macrophage populations and a network of innate and innate-like lymphocytes, such as natural killer cells, innate lymphoid cells, and invariant T cells. Lung-resident memory T and B cells contribute to this network following initial exposure to antigenic stimuli. This review explores how advances in the study of human immunology have shaped our understanding of this resident immune network and its response to two of the most commonly encountered inflammatory stimuli in the airways: viruses and allergens. It discusses the many ways in which pathogenic infection and allergic inflammation mirror each other, highlighting the key checkpoints at which they diverge and how this can result in a lifetime of allergic exacerbation versus protective anti-viral immunity.

摘要

人体呼吸道的免疫由多种组织驻留细胞提供,包括特化的上皮细胞和巨噬细胞群体,以及先天和类先天淋巴细胞网络,如自然杀伤细胞、固有淋巴细胞和不变 T 细胞。肺驻留记忆 T 和 B 细胞在最初接触抗原刺激后有助于形成这个网络。这篇综述探讨了人类免疫学研究的进展如何塑造了我们对这种常驻免疫网络及其对呼吸道中两种最常见炎症刺激物(病毒和过敏原)的反应的理解。它讨论了致病性感染和过敏性炎症相互模仿的许多方式,强调了它们分歧的关键检查点以及这如何导致终生过敏加重与保护性抗病毒免疫。

相似文献

1
Overlapping and distinct features of viral and allergen immunity in the human lung.人类肺部病毒和过敏原免疫的重叠和独特特征。
Immunity. 2021 Apr 13;54(4):617-631. doi: 10.1016/j.immuni.2021.03.010.
2
Innate lymphoid cells: the role in respiratory infections and lung tissue damage.固有淋巴细胞:在呼吸道感染和肺组织损伤中的作用。
Expert Rev Clin Immunol. 2017 Oct;13(10):991-999. doi: 10.1080/1744666X.2017.1366314. Epub 2017 Aug 21.
3
Anatomical features of anti-viral immunity in the respiratory tract.呼吸道抗病毒免疫的解剖学特征。
Semin Immunol. 2004 Jun;16(3):163-70. doi: 10.1016/j.smim.2004.02.003.
4
The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.固有淋巴细胞和非常规 T 细胞在慢性炎症性肺病中的影响。
Front Immunol. 2019 Jul 11;10:1597. doi: 10.3389/fimmu.2019.01597. eCollection 2019.
5
Group 2 innate lymphoid cells in the lung.肺中的2型固有淋巴细胞
Adv Immunol. 2014;124:1-16. doi: 10.1016/B978-0-12-800147-9.00001-7.
6
Innate Immunity of the Lung.肺的固有免疫
J Innate Immun. 2020;12(1):1-3. doi: 10.1159/000504621. Epub 2019 Dec 4.
7
IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation.IL-33 介导体液免疫和适应性免疫细胞促进蛋白酶过敏原诱导的过敏性气道炎症的最大反应。
J Immunol. 2013 May 1;190(9):4489-99. doi: 10.4049/jimmunol.1201212. Epub 2013 Apr 1.
8
Inflammatory monocytes contribute to the persistence of CXCR3 CX3CR1 circulating and lung-resident memory CD8 T cells following respiratory virus infection.炎症单核细胞有助于呼吸道病毒感染后 CXCR3+CX3CR1+循环和肺驻留记忆 CD8+T 细胞的持续存在。
Immunol Cell Biol. 2018 Apr;96(4):370-378. doi: 10.1111/imcb.12006. Epub 2018 Jan 30.
9
Neutrophil subset responses in infants with severe viral respiratory infection.患有严重病毒性呼吸道感染的婴儿中性粒细胞亚群反应
Clin Immunol. 2017 Mar;176:100-106. doi: 10.1016/j.clim.2016.12.012. Epub 2017 Jan 17.
10
Pulmonary immunity to viruses.肺部对病毒的免疫
Clin Sci (Lond). 2017 Jun 30;131(14):1737-1762. doi: 10.1042/CS20160259. Print 2017 Jul 15.

引用本文的文献

1
Distinct phenotypes and repertoires of bronchoalveolar and airway mucosal T cells in health and allergic asthma.健康和过敏性哮喘中支气管肺泡及气道黏膜T细胞的不同表型和库
bioRxiv. 2025 May 13:2025.05.08.652962. doi: 10.1101/2025.05.08.652962.
2
Location, Location, Location: Spatial Immune-Stroma Crosstalk Drives Pathogenesis in Asthma.位置,位置,位置:空间免疫-基质相互作用驱动哮喘发病机制
Immunol Rev. 2025 Mar;330(1):e70013. doi: 10.1111/imr.70013.
3
Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression.
粒细胞集落刺激因子(G-CSF)导致肺泡巨噬细胞中IRF8表达下调,从而促进转移性肿瘤进展。
iScience. 2024 Feb 10;27(3):109187. doi: 10.1016/j.isci.2024.109187. eCollection 2024 Mar 15.
4
Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs.SARS-CoV-2 感染的时空分析显示,单核细胞衍生的巨噬细胞呈扩张波状,与仓鼠肺部的血管损伤和病毒清除有关。
Microbiol Spectr. 2024 Jan 11;12(1):e0246923. doi: 10.1128/spectrum.02469-23. Epub 2023 Nov 27.
5
Remodeling and Restraining Lung Tissue Damage Through the Regulation of Respiratory Immune Responses.通过调节呼吸免疫应答来重塑和抑制肺组织损伤。
Tissue Eng Regen Med. 2023 Jun;20(3):329-339. doi: 10.1007/s13770-022-00516-7. Epub 2023 Feb 10.
6
TLR7 controls myeloid-derived suppressor cells expansion and function in the lung of C57BL6 mice infected with Schistosoma japonicum.TLR7 控制感染日本血吸虫的 C57BL6 小鼠肺部髓源抑制细胞的扩增和功能。
PLoS Negl Trop Dis. 2022 Oct 24;16(10):e0010851. doi: 10.1371/journal.pntd.0010851. eCollection 2022 Oct.
7
The emerging role of NOTCH3 receptor signalling in human lung diseases.NOTCH3 受体信号通路在人类肺部疾病中的新兴作用。
Expert Rev Mol Med. 2022 Sep 2;24:e33. doi: 10.1017/erm.2022.27.
8
Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma.哮喘中 Th1、Th2 和 Th17 细胞的独特时空作用。
Front Immunol. 2022 Aug 12;13:974066. doi: 10.3389/fimmu.2022.974066. eCollection 2022.
9
Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.推进肺部免疫学研究:美国胸科学会官方研讨会报告。
Am J Respir Cell Mol Biol. 2022 Jul;67(1):e1-18. doi: 10.1165/rcmb.2022-0167ST.
10
Mucosal immune responses to infection and vaccination in the respiratory tract.呼吸道感染和疫苗接种的黏膜免疫应答。
Immunity. 2022 May 10;55(5):749-780. doi: 10.1016/j.immuni.2022.04.013.